AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Remuneration Information Jan 23, 2025

7734_dirs_2025-01-23_d9a49ced-dea8-47d4-8690-d28e6e9c4bcd.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3650U

Judges Scientific PLC

23 January 2025

23 January 2025

Judges Scientific plc

("Judges Scientific" or the "Company")

Grant of Options

Judges Scientific announces that it has issued options over 76,500 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price per share of £76.90, being the closing mid-price on 22 January 2025.

76,500 options have been awarded in total by the Remuneration Committee to certain of the Directors, as shown in the table below, to retain and incentivise them. Vesting of the options after three years is subject to the achievement of 5% compound growth in adjusted earnings per share over the vesting period, and to continued employment.

Director Number of options Option Scheme Vesting date Expiry date
Tim Prestidge 60,000 Unapproved 23/01/2028 22/01/2035
David Cicurel 5,500 Unapproved 23/01/2028 22/01/2035
Brad Ormsby 5,500 Unapproved 23/01/2028 22/01/2035
Mark Lavelle 5,500 Unapproved 23/01/2028 22/01/2035

The Remuneration Committee seeks through its award of share options to motivate, retain and incentivise executives of the calibre that will grow shareholder value successfully.  The share option awards align the interests of executives and shareholders.  Tim Prestidge, Group Business Development Director, has been issued additional options as his original share options from the time of his appointment, which were granted on 31 March 2023, were issued with a 10% compound growth rate, prior to the enactment of the increase in UK corporation tax from 19% to 25%. In this context, the Remuneration Committee consider such compound performance target to be overly ambitious for the vesting period. 

Further it is noted that the Company erroneously omitted disclosing the issue of share options to Ian Wilcock, Group Commercial Director, when he joined the Company. The award of options, which was made on 19 September 2024, is summarised below.

Director Number of options Exercise price Option Scheme Vesting date Expiry date
Ian Wilcock 305 £98.30 Approved 19/09/2027 19/09/2034
Ian Wilcock 29,695 £98.30 Unapproved 19/09/2027 19/09/2034
For further information please contact:
Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Joshua Borlant

Tel : +44 (0) 20 3100 2222
Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000
Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Sarah Peters

Tel: +44 (0) 20 3405 0205

[email protected]

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

Judges Scientific plc

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Cicurel

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
7690p 5,500

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

23/01/2025

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Judges Scientific plc

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bradley Ormsby

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
7690p 5,500

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

23/01/2025

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Judges Scientific plc

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Lavelle

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
7690p 5,500

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

23/01/2025

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Judges Scientific plc

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tim Prestidge

2

Reason for the notification

a)

Position/status

Group Business Development Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
7690p 60,000

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

23/01/2025

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Judges Scientific plc

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Wilcock

2

Reason for the notification

a)

Position/status

Group Commercial Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
9830p 30,000

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

19/09/2024

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDGGDBLBDDGUD

Talk to a Data Expert

Have a question? We'll get back to you promptly.